Novel Approaches for Improving Vascular Function in Veterans With HFpEF
VA Office of Research and Development
90 participants
May 19, 2021
INTERVENTIONAL
Conditions
Summary
This project will evaluate the impact of L-Citrulline, tetrahydrobiopterin (BH4), and atorvastatin administration on physical capacity and vascular function in Veterans with heart failure with preserved ejection fraction (HFpEF).
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
100 mg tablet
L-Citrulline-matched Placebo tablet
10mg/kg
BH4-matched Placebo
10 mg tablet
Atorvastatin-matched Placebo
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06312748